Want to join the conversation?
$GILD said that its two Phase 3 clinical trials (Studies 108 & 110) met their primary objectives. $GILD stated that it plans to submit regulatory applications for tenofovir alafenamide for chronic hepatitis B virus in the US and the EU in 1Q16. The company plans to submit data from both studies for presentation to a scientific conference in 2016.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?